Leerink Partnrs Has Bullish Outlook for THC Q3 Earnings

Tenet Healthcare Corporation (NYSE:THC) – Equities research analysts at Leerink Partnrs boosted their Q3 2025 EPS estimates for Tenet Healthcare in a research report issued to clients and investors on Wednesday, October 22nd. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $3.15 per share for the quarter, up from their prior estimate of $3.13. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $4.51 EPS.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.84 by $1.18. The company had revenue of $5.27 billion during the quarter, compared to analysts’ expectations of $5.16 billion. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. Tenet Healthcare’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.31 earnings per share.

A number of other equities research analysts have also recently issued reports on THC. Truist Financial set a $225.00 target price on shares of Tenet Healthcare in a research report on Tuesday, October 14th. The Goldman Sachs Group began coverage on shares of Tenet Healthcare in a research report on Tuesday, October 14th. They issued a “buy” rating and a $224.00 target price for the company. UBS Group upped their price objective on shares of Tenet Healthcare from $230.00 to $238.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Bank of America upped their price objective on shares of Tenet Healthcare from $205.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Finally, Zacks Research cut shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average target price of $209.25.

Tenet Healthcare Trading Up 1.3%

Shares of Tenet Healthcare stock opened at $204.99 on Thursday. The firm has a 50-day moving average of $191.24 and a 200-day moving average of $168.33. The stock has a market cap of $18.11 billion, a PE ratio of 13.12, a PEG ratio of 0.87 and a beta of 1.52. Tenet Healthcare has a 52-week low of $109.82 and a 52-week high of $207.14. The company has a debt-to-equity ratio of 2.39, a quick ratio of 1.63 and a current ratio of 1.71.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of Tenet Healthcare in the first quarter valued at approximately $26,000. Chung Wu Investment Group LLC acquired a new position in shares of Tenet Healthcare in the second quarter valued at approximately $35,000. Trust Co. of Vermont acquired a new position in shares of Tenet Healthcare in the third quarter valued at approximately $41,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the second quarter valued at approximately $35,000. Finally, Wayfinding Financial LLC acquired a new position in shares of Tenet Healthcare in the first quarter valued at approximately $28,000. Institutional investors own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other news, EVP Lisa Y. Foo sold 8,000 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $179.53, for a total value of $1,436,240.00. Following the completion of the transaction, the executive vice president owned 20,878 shares of the company’s stock, valued at approximately $3,748,227.34. This represents a 27.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Saumya Sutaria sold 78,762 shares of the stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $190.78, for a total transaction of $15,026,214.36. Following the completion of the transaction, the chief executive officer directly owned 368,683 shares of the company’s stock, valued at $70,337,342.74. This trade represents a 17.60% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 90,722 shares of company stock valued at $17,161,015. 0.81% of the stock is currently owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.